Healthcare Industry News: Osteoporosis
News Release - September 28, 2012
EffRx Names Lorenzo Bosisio Vice President, Head of Business Development and MarketingFREIENBACH, Switzerland, September 28, 2012 -- (Healthcare Sales & Marketing Network) -- EffRx Pharmaceuticals SA is proud to announce and welcome Lorenzo Bosisio, new Head of Business Development and Marketing. Lorenzo will be responsible for the outlicensing and marketing of EffRx's approved product Steovess«/Binosto[TM] outside of the USA and Canada as well as developing the business for EffRx's other pipeline products.
Lorenzo brings broad international commercial experience to our organization.
The former Intl. Senior Marketing Manager for New Products & Osteoporosis for Amgen has also held senior positions at ALEXION Pharma, Tissot Medical Research, and PWC. He has obtained vast experience in terms of Brand Strategy, Product Launches, Leadership and General Management.
"We are very pleased to have Lorenzo Bosisio join EffRx. He has the background we were looking for to fill this important position. He is a strategic thinker and good communicator, which will be of great value for EffRx," comment Christer RosÚn, Chairman and CEO.
Lorenzo is fluent in several languages and holds a BSc degree in Business Administration (majors Finance and Marketing) as well as an MBA from HEC School of Management, Paris and MBA International Exchange Program from London Business School.
EffRx is a privately held drug delivery technology company specializing in the utilization of proprietary effervescent technology to develop formulations that improve efficiency, compliance and convenience of existing prescription drugs.
For additional information please visit the EffRx website http://www.effrx.com
Source: EffRx Pharmaceuticals
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.